A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age

被引：0
|
作者：
Lewis, D. [1 ]
Winner, P. [2 ]
Saper, J. [3 ]
Ness, S. [4 ]
Polverejan, E. [5 ]
Kurland, C. [6 ]
Ford, L. [4 ]
Eerdekens, M. [7 ]
机构：
[1] Childrens Hosp Kings Daughters, Eastern Virginia Med Sch, Div Pediat Neurol, Norfolk, VA USA
[2] Palm Beach Headache Ctr, W Palm Beach, FL USA
[3] Michigan Head Pain & Neurol Inst, Ann Arbor, MI USA
[4] Johnson & Johnson Pharmaceut Res & Dev LLC, CNS Pain & Translat Med, Titusville, NJ USA
[5] Johnson & Johnson Pharmaceut Res & Dev LLC, Clin Biostat, Titusville, NJ USA
[6] Johnson & Johnson Pharmaceut Res & Dev LLC, CNS Pain & Mature Prod TA Operat, Titusville, NJ USA
[7] Johnson & Johnson Pharmaceut Res & Dev LLC, CNS Analgesia, Antwerp, Belgium
来源：
HEADACHE | 2008年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S8 / S9
页数：2
相关论文
共 50 条
  • [21] A Phase 2/3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant for the Preventive Treatment of Migraine
    Croop, R.
    Lipton, R. B.
    Kudrow, D.
    Stock, D. A.
    Kamen, L.
    Conway, C. M.
    Stock, E. G.
    Coric, V.
    Goadsby, P. J.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 28 - 29
  • [22] A phase 2/3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rimegepant for the preventive treatment of migraine
    Croop, R.
    Lipton, R. B.
    Kudrow, D.
    Stock, D. A.
    Kamen, L.
    Conway, C. M.
    Stock, E. G.
    Coric, V
    Goadsby, P. J.
    HEADACHE, 2021, 61 : 98 - 99
  • [23] A Phase 2/3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant for the Preventive Treatment of Migraine
    Croop, Robert
    Lipton, Richard
    Thiry, Alexandra
    Kamen, Lisa
    Coric, Vlad
    Goadsby, Peter
    NEUROLOGY, 2021, 96 (15)
  • [24] A Phase 2/3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant for the Preventive Treatment of Migraine
    Croop, R.
    Lipton, R. B.
    Kudrow, D.
    Stock, D. A.
    Kamen, L.
    Conway, C. M.
    Stock, E. G.
    Coric, V.
    Goadsby, P. J.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 19 - 19
  • [25] RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF FEVERFEW IN MIGRAINE PREVENTION
    MURPHY, JJ
    HEPTINSTALL, S
    MITCHELL, JRA
    LANCET, 1988, 2 (8604): : 189 - 192
  • [26] Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: A randomized, double-blind, placebo-controlled study
    Tucker, Phebe
    Trautman, Richard P.
    Wyatt, Dorothy B.
    Thompson, Jamie
    Wu, Shu-Chen
    Capece, Julie A.
    Rosenthal, Norman R.
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (02) : 201 - 206
  • [27] Efficacy and safety of topiramate in combination with metformin in the treatment of obese subjects with type 2 diabetes: a randomized, double-blind, placebo-controlled study
    H Toplak
    A Hamann
    R Moore
    E Masson
    M Gorska
    F Vercruysse
    X Sun
    M Fitchet
    International Journal of Obesity, 2007, 31 : 138 - 146
  • [28] Efficacy and safety of topiramate in combination with metformin in the treatment of obese subjects with type 2 diabetes: a randomized, double-blind, placebo-controlled study
    Toplak, H.
    Hamann, A.
    Moore, R.
    Masson, E.
    Gorska, M.
    Vercruysse, F.
    Sun, X.
    Fitchet, M.
    INTERNATIONAL JOURNAL OF OBESITY, 2007, 31 (01) : 138 - 146
  • [29] Randomized double-blind placebo-controlled crossover study to evaluate the efficacy and safety of a green coffee bean extract in overweight subjects
    Vinson, Joe A.
    Burnham, Bryan
    Nagendran, Mysore V.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [30] Double-blind, randomized, placebo-controlled study to evaluate the efficacy and tolerability of rizatriptan with acetaminophen for the acute treatment of migraine
    Freitag, F. G.
    Diamond, M. L.
    Skobieranda, F.
    Diamond, S.
    HEADACHE, 2007, 47 (05): : 749 - 749
12345